The next chapter for group B meningococcal vaccines
The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...
मुख्य लेखकों: | Wang, N, Pollard, A |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Taylor and Francis
2017
|
समान संसाधन
-
Group B meningococcal vaccine science and policy
द्वारा: Drysdale, SB, और अन्य
प्रकाशित: (2015) -
Group B meningococcal vaccine: Recommendations for UK use
द्वारा: Pollard, A, और अन्य
प्रकाशित: (2014) -
Group B meningococcal vaccine: recommendations for UK use.
द्वारा: Pollard, A, और अन्य
प्रकाशित: (2014) -
Four component meningococcal capsular Group B vaccine in preterm infants.
द्वारा: Sadarangani, M, और अन्य
प्रकाशित: (2017) -
Meningococcal vaccines.
द्वारा: Rüggeberg, J, और अन्य
प्रकाशित: (2004)